“ISpectra Technologies brought deep expertise in cybersecurity and DevSecOps to our projects, playing a crucial role in our EDR Tool implementations and SOC 2 compliance. Their solutions were tailored to our business and their proactive approach improved both our agility and security posture. ISpectra felt more like an extension of our team than an external vendor.”
SOC 2 Certification for Pharmaceuticals
— Type I in 2 Months, Type II in 4
A SOC 2 consulting partner built for Drug discovery & R&D, Clinical trials & CRO and Manufacturing & GxP. We get you SOC 2 Certification for Pharmaceuticals end-to-end — from readiness assessment to a clean CPA-attested Type I and Type II report.
As certified partners of Drata, Sprinto and Secureframe, we operationalise every Trust Services Criterion inside the tools engineering already runs — AWS, Azure, GCP, GitHub, Okta and Jira — so evidence is collected automatically across the observation window.
Why Pharmaceuticals Companies Can No Longer Skip SOC 2
Pharma firms hold research IP, clinical-trial data and patient information of immense value. Sponsors, CROs and enterprise partners require a SOC 2 report before they share regulated data and systems. Without it, research collaborations and data agreements stall.
SOC 2 Certification for Pharmaceuticals is the AICPA-recognised attestation that an independent CPA firm has examined your controls against the five Trust Services Criteria — Security, Availability, Processing Integrity, Confidentiality and Privacy. A Type I report proves your controls are well-designed; a Type II report proves they actually operated effectively across an observation window of about 4 months. To an enterprise buyer, that report is the difference between “approved vendor” and “rejected”.
We map criteria to regulated R&D and manufacturing — research-IP protection, GxP and 21 CFR Part 11 system access, clinical-data integrity, and partner oversight. SOC 2 evidence complements your validated environment so sponsors and CROs can share data confidently.
The Real Business Cost of Skipping SOC 2 Certification for Pharmaceuticals
For B2B Pharmaceuticals companies, no SOC 2 report is a measurable drag on revenue, sales velocity and buyer trust.
Lost enterprise deals
Sponsors, CROs and enterprise partners require a SOC 2 report before sharing regulated data and systems.
Breach exposure
Loss of research IP or trial data is irreversible and immensely costly; uncertified firms face heightened risk.
Slower sales cycles
Without SOC 2, research collaborations and data-sharing agreements stall.
Regulatory & insurance pressure
GxP, 21 CFR Part 11 and HIPAA increasingly expect audited security controls.
Our 6-Stage SOC 2 Certification for Pharmaceuticals Process
Click through the timeline — or hit play and watch the sprint run. Most Pharmaceuticals clients reach SOC 2 Type I in about 2 months, then SOC 2 Type II in about 4 months.
The 5 Trust Services Criteria, mapped to your Pharmaceuticals stack
How we operationalise each Trust Services Criterion — in the tools your engineers already run, with evidence captured automatically in Drata, Sprinto or Secureframe.
Security · Mandatory
Access control, change management, risk assessment and continuous monitoring across your GxP systems, ELN/LIMS and clinical-data stores.
Availability · Optional
Uptime, resilience and tested recovery so the services delivering your research IP and clinical-trial data stay available as committed.
Processing Integrity · Optional
Complete, valid, accurate and timely processing of research IP and clinical-trial data.
Confidentiality · Optional
Encryption, classification and least-privilege protection for research IP and clinical-trial data.
Privacy · Optional
Lawful collection, use, retention and disposal of the personal data across your GxP systems, ELN/LIMS and clinical-data stores.
Evidence, collected automatically
Each criterion maps to controls captured continuously — no screenshot scramble before the CPA examination.
Pharmaceuticals Sub-Verticals We Certify
Tailored SOC 2 Certification for Pharmaceuticals engagements designed around the data flows and buyer expectations of every Pharmaceuticals business model.
Drug discovery & R&D
Research platforms and labs handling proprietary IP.
Clinical trials & CRO
Trial-management and CRO platforms processing patient data.
Manufacturing & GxP
GxP, MES and quality-management systems.
Pharmacovigilance
Safety, adverse-event and PV data platforms.
Regulatory & RIM
Regulatory-information-management and submission tools.
Commercial & supply
Distribution, serialization and commercial platforms.
Frameworks Pharmaceuticals teams run alongside SOC 2
SOC 2 reuses most of the same controls as the standards your Pharmaceuticals buyers, regulators and auditors already expect — so one control set satisfies many. We map the overlap and reuse up to 80% of your evidence.
GxP / GAMP 5
Good-practice computerised-system controls.
21 CFR Part 11
Electronic records and signatures.
HIPAA
For clinical and patient data.
ISO 27001
ISMS certification overlapping SOC 2.
GDPR
For EU trial-participant data.
SOC 2 Processing Integrity
Trial-data accuracy and completeness.
The Pharmaceuticals security risks SOC 2 puts under control
The Trust Services Criteria map directly to the threats that matter most in Pharmaceuticals — here is what your SOC 2 programme is built to contain.
Research-IP theft
Loss of proprietary compounds, methods and data.
Clinical-data integrity failure
Tampered or incomplete trial records.
Pharmacovigilance exposure
Leakage of adverse-event and patient data.
Partner & CRO risk
Collaborator weaknesses exposing regulated data.
Without a report, or SOC 2 attested — side by side
The reality for a B2B Pharmaceuticals company, both views at a glance.
The real cost of doing nothing
- ×Sponsors, CROs and enterprise partners screen you out before the first call without a report
- ×Every Pharmaceuticals security review restarts from a blank questionnaire
- ×Higher exposure for research IP and clinical-trial data with no attested controls
- ×Tougher cyber-insurance terms & longer GxP / GAMP 5 / 21 CFR Part 11 audits
- ×One failed review erodes hard-won Pharmaceuticals trust
The upside of getting attested
- ✓Clear sponsors, CROs and enterprise partners procurement the day your report is issued
- ✓30–45% faster Pharmaceuticals sales cycles with a pre-built CAIQ / SIG
- ✓Stronger cyber-insurance terms with attested controls over research IP and clinical-trial data
- ✓One control set reused across GxP / GAMP 5, 21 CFR Part 11 and HIPAA
- ✓Engineering hours returned through automated evidence
SOC 2 Type I vs Type II
SOC 2 Type I
Point-in-time- Attests controls are suitably designed on a specific date
- ~2 months from kickoff
- Fastest way to answer a buyer asking for SOC 2 now
SOC 2 Type II
Over a period- Attests controls operated effectively over a ~4-month window
- The report most enterprise buyers ultimately require
- Continuous evidence, renewed annually on a rolling basis
What’s a stuck deal worth?
Illustrative estimate only — based on the numbers you enter.
Why Leading Pharmaceuticals Companies Choose ISpectra for SOC 2
A specialist consultancy delivering SOC 2 Certification for Pharmaceuticals firms across the US, India, the EU and the Middle East — with a 100% first-attempt audit pass record.
To Type I report
Fastest fixed-fee delivery in the industry — kickoff to a clean CPA-attested Type I report.
Compliance automation partner
Certified partner of Drata, Sprinto and Secureframe — lower licensing and faster evidence.
First-attempt audit pass
Zero failed examinations across 200+ engagements — every issue caught in our internal audit.
Get a fixed-fee, written quote for your SOC 2 programme within 48 hours of your readiness call.
Trusted by 200+ Global Enterprise Clients






























Real B2B Results from
Real Partnerships
Frequently Asked SOC 2 Questions
Everything Pharmaceuticals founders, CTOs and security leads ask before starting SOC 2.
SOC 2 is an AICPA attestation in which a licensed CPA firm examines your controls against the five Trust Services Criteria. For Pharmaceuticals, MSPs and cloud providers it is the universally accepted proof that customer data is handled securely — and is the default qualifying filter in most North American enterprise vendor reviews.
Type I attests that your controls are suitably designed at a single point in time. Type II attests that those controls operated effectively across an observation window of about 4 months. Most enterprise buyers ultimately require Type II, so we get you Type I in about 2 months then support the observation period.
Most Pharmaceuticals companies reach Type I in about 2 months with our fixed-fee model, then Type II in about 4 months after the observation window. Larger multi-product Pharmaceuticals groups running ISO 27001 in parallel may take a little longer.
Security (the Common Criteria) is mandatory. Most Pharmaceuticals platforms add Availability and Confidentiality; Processing Integrity and Privacy are scoped in for payments, analytics and PII-heavy products. We help you scope the right criteria to match buyer demand without over-auditing.
A SOC 2 report covers a defined period and is generally refreshed every 12 months. Buyers typically expect a report no older than a year, so Pharmaceuticals companies run a rolling annual Type II. We support the full lifecycle, including bridge letters between report dates.
Yes — and most Pharmaceuticals clients do. SOC 2 controls overlap heavily with ISO 27001 Annex A and HIPAA safeguards. Running them together reuses up to 80% of the same evidence and saves around 40% versus sequential audits.
B2B Pharmaceuticals platforms, MSPs and MSSPs, cloud service providers, software engineering firms, IT consulting and staffing groups, and data/AI platforms selling into US enterprise, healthcare or finance — where a SOC 2 report is a routine prerequisite to close.
A licensed independent CPA firm issues the SOC 2 attestation report — not ISpectra. We prepare your environment, run the internal audit and coordinate the CPA examination end-to-end, so your team stays focused on shipping product.
ISpectra handles the heavy lifting — readiness and risk assessment, 30+ policies, control rollout, internal audit, management review and CPA coordination. Your team provides inputs, approves deliverables and runs day-to-day operations — typically under 10% of one FTE through the sprint.
Ready to Start Your
SOC 2 Certification for Pharmaceuticals?
What you receive
- Written readiness-gap report
- Recommended Trust Services Criteria scope
- Fixed-fee quote in 48 hours
- Type I → Type II roadmap
- Compliance-automation platform pick
- 1-hour call with a SOC 2 Lead
No obligation · Results in 48 hours · 100% confidential
Schedule a Call
Pick a time that works for you
Request Assessment
Our team responds within 24 hours
Start Your SOC 2 Certification for Pharmaceuticals Sprint Today
Talk to a SOC 2 Lead for the Pharmaceuticals industry. Get a fixed-fee roadmap and a written readiness report — on us.
SOC 2 Certification — Other Industries We Serve
Industry-specific SOC 2 readiness & attestation across regulated and B2B sectors
Explore our full SOC 2 Compliance & Attestation Services →